Cutler Group LP Adverum Biotechnologies, Inc. Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 26, 2021	SELL	$9.26 - $14.36 $4,630 - $7,180	-500 Closed	0 $0
Q3 2020 Oct 27, 2020	SELL	$10.3 - $21.64 $4,120 - $8,656	-400 Reduced 44.44%	500 $5,000
Q2 2020 Jul 22, 2020	SELL	$8.53 - $25.64 $16,206 - $48,716	-1,900 Reduced 67.86%	900 $18,000
Q1 2020 May 07, 2020	SELL	$7.98 - $16.32 $6,384 - $13,056	-800 Reduced 22.22%	2,800 $27,000
Q4 2019 Feb 06, 2020	SELL	$5.12 - $12.22 $16,384 - $39,104	-3,200 Reduced 47.06%	3,600 $41,000
Q3 2019 Oct 28, 2019	BUY	$5.24 - $15.89 $35,632 - $108,052	6,800 New	6,800 $37,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $424M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.